# Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion

Study · id `cardio:ct-nct05671276` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05671276](<https://clinicaltrials.gov/study/NCT05671276>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05671276

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05671276. Randomized; single masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2024-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05671276, source copy `cardio:ctgov-nct05671276-2023-01-04`, retrieved 2026-10-26)
- Started: 2022-02-01 (actual) (ClinicalTrials.gov record NCT05671276, source copy `cardio:ctgov-nct05671276-2023-01-04`, retrieved 2026-10-26)
- Primary completion: 2024-09-01 (anticipated) (ClinicalTrials.gov record NCT05671276, source copy `cardio:ctgov-nct05671276-2023-01-04`, retrieved 2026-10-26)
- Completion: 2024-09-01 (anticipated) (ClinicalTrials.gov record NCT05671276, source copy `cardio:ctgov-nct05671276-2023-01-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05671276, source copy `cardio:ctgov-nct05671276-2023-01-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05671276-2023-01-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion
- Condition: Atrial Fibrillation
- Condition: Left Atrial Appendage Occlusion
- Condition: Silent Cerebral Embolism
- Intervention (Drug): aspirin and clopidogrel
- Intervention (Drug): Rivaroxaban
- Lead sponsor: The First Affiliated Hospital with Nanjing Medical University
- Lead sponsor class: OTHER
- Collaborator: Second Affiliated Hospital of Nantong University
- Collaborator class: OTHER
- Collaborator: Jiangsu Taizhou People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Rivaroxaban (`cardio:rivaroxaban`)
- Registry lists this organization as the lead sponsor: The First Affiliated Hospital with Nanjing Medical University (`cardio:org-the-first-affiliated-hospital-with-nanjing-medical-898271`)
- Registry lists this organization as a collaborator: Jiangsu Taizhou People's Hospital (`cardio:org-jiangsu-taizhou-people-s-hospital`)

## Provenance

Content hash: 5d06aa7a5fb84b462ab2db6a78074f8c960e62e64f5e7fad7d3eec9bbcd04c3a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
